Lakeside Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$941K Sell
10,905
-663
-6% -$58.4K 0.55% 31
2026
Q2
$905K Sell
11,568
-292
-2% -$23.6K 0.57% 34
2026
Q1
$1.03M Sell
11,860
-93
-0.8% -$8.91K 0.69% 29
2025
Q4
$1.15M Sell
11,953
-1,193
-9% -$116K 0.73% 26
2025
Q3
$1.25M Sell
13,146
-243
-2% -$22.3K 0.79% 24
2025
Q2
$1.17M Buy
13,389
+8
+0.1% +$678 0.75% 26
2025
Q1
$1.2M Buy
13,381
+8
+0.1% +$716 0.8% 26
2024
Q4
$1.07M Sell
13,373
-1,795
-12% -$155K 0.71% 26
2024
Q3
$1.37M Sell
15,168
-243
-2% -$20.4K 0.86% 24
2024
Q2
$1.21M Sell
15,411
-794
-5% -$65.1K 0.79% 24
2024
Q1
$1.41M Sell
16,205
-194
-1% -$16.6K 0.9% 23
2023
Q4
$1.35M Sell
16,399
-1,193
-7% -$90.9K 0.94% 24
2023
Q3
$1.38M Sell
17,592
-95
-0.5% -$7.95K 1.06% 22
2023
Q2
$1.56M Sell
17,687
-94
-0.5% -$8.09K 1.15% 21
2023
Q1
$1.43M Buy
17,781
+6
+0% +$489 1.11% 22
2022
Q4
$1.38M Sell
17,775
-294
-2% -$23.8K 1.13% 20
2022
Q3
$1.46M Buy
18,069
+9,808
+119% +$881K 1.31% 17
2022
Q2
$741K Buy
+8,261
New +$837K 0.63% 30

Other funds holding MDT

Lakeside Advisors's MDT Position: Q3 2026 in Review

Lakeside Advisors reduced its Medtronic (MDT) stake by 5.7% in Q3 2026, selling an estimated $58.4K and leaving 10,905 shares worth $941K. The position accounts for 0.55% of the portfolio, ranked #31.

Lakeside Advisors first reported a position in MDT in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.56M in Q2 2023. 1,676 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Lakeside Advisors held 10,905 shares of Medtronic worth $941K as of Q3 2026.
  • Lakeside Advisors sold 663 Medtronic shares in Q3 2026, an estimated $58.4K.
  • Medtronic made up 0.55% of Lakeside Advisors's portfolio in Q3 2026, its #31 holding.
  • Lakeside Advisors first reported a position in Medtronic in Q2 2022 and has held it in 18 quarters since.
  • Lakeside Advisors's Medtronic position peaked at $1.56M in Q2 2023.
  • 1,676 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Lakeside Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.